Recent studies have converged on the overlap of GLP-1|glucose-dependent insulinotropic polypeptide|GCGR activator therapies and DA communication. While GLP stimulators are widely employed for treating type 2 T2DM, their emerging impacts on reinforcement circuits, specifically governed by dopamine networks, are receiving considerable focus. This … Read More